Beijing, China

Liang Qu

This inventor holds 2 USPTO granted patents and 20 published patent applications and 3 EPO patents. Top assignees: Peking University, Edigene Therapeutics (Beijing) Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liang Qu. Retrieved from https://idiyas.com/inventor/liang-qu-a9wuqm2c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.8

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Liang Qu

Introduction

Liang Qu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of RNA editing, holding 2 patents that showcase his innovative approaches. His work focuses on developing methods and compositions that enhance the precision of RNA editing.

Latest Patents

Liang Qu's latest patents include "Methods and compositions for editing RNAs" and "Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs." The first patent provides methods for editing RNA by introducing a deaminase-recruiting RNA in a host cell for deamination of an adenosine in a target RNA. The second patent outlines similar methods, emphasizing the use of deaminase-recruiting RNAs in RNA editing techniques, along with compositions and kits that incorporate these innovations.

Career Highlights

Throughout his career, Liang Qu has worked with esteemed institutions such as Peking University and Edigene Therapeutics (Beijing) Inc. His research has significantly advanced the understanding and application of RNA editing technologies.

Collaborations

Liang has collaborated with notable colleagues, including Wensheng Wei and Zongyi Yi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Liang Qu's contributions to RNA editing through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in genetic research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…